ShareValue scores for 0928.HK: Valuation 48, Quality 40, Growth 57, Health 65.

0928.HK
HKEX

Life Healthcare

HK$0.11(+3.92%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 17%
Valuation
48
Fair Value
Price vs Value
Quality
40
Weak
Business Strength
Growth
57
Moderate
Revenue & Earnings
Health
65
Moderate
Financial Stability
Momentum
63
Bullish
Price Trend

Company Details

About

King International Investment Limited, an investment holding company, provides genetic testing and health data analysis services in the People's Republic of China and Hong Kong. The company operates through two segments, Healthcare Products and Services Business, and Money Lending Business. The company also engages in money lending activities. In addition, it provides corporate administrative and healthcare services. The company was formerly known as Life Healthcare Group Limited and changed its name to King International Investment Limited in December 2023. King International Investment Limited was incorporated in 2001 and is based in Central, Hong Kong.

Score Analysis

AI Investment Thesis

Data as of:Aug 5, 2026
|
Last calculated:Aug 5, 2026